• Anixa Biosciences CEO Amit Kumar bought 5,000 common shares at USD 3.46 each.
• Directly held stake rose to 640,812 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anixa Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-034027), on July 21, 2026, and is solely responsible for the information contained therein.